|
Market Closed -
London S.E.
11:35:07 2026-09-02 EDT
|
5-day change | 1st Jan Change | ||
| 1,861.50 GBX | -0.53% |
|
-2.31% | +2.03% |
| 09-02 | GSK plc : Deutsche Bank reiterates its Neutral rating | ZD |
| 09-01 | Gsk Advances Mrna Flu Vaccine Candidate to Phase Iii Following Positive Phase Ii Data | CI |
| Market Cap | 74.59B 101B 86.91B 81.87B 139B 9,516B 140B 969B 376B 4,865B 378B 370B 15,982B | P/E 2026 * |
14.1x | P/E 2027 * | 11.5x |
|---|---|---|---|---|---|
| Enterprise Value | 94.43B 128B 110B 104B 177B 12,047B 178B 1,227B 476B 6,159B 479B 468B 20,233B | EV / Sales 2026 * |
2.78x | EV / Sales 2027 * | 2.58x |
| Free-Float |
92.75% | Yield 2026 * |
3.74% | Yield 2027 * | 4.03% |
Last Transcript : GSK plc
| 1 day | -0.53% | ||
| 1 week | -2.31% | ||
| Current month | +0.43% | ||
| 1 month | -3.62% | ||
| 3 months | +1.03% | ||
| 6 months | -15.42% | ||
| Current year | +2.03% |
| 1 week | 1,839 |  | 1,903 |
| 1 month | 1,803 | | 1,972 |
| Current year | 1,690 | | 2,282 |
| 1 year | 1,444.5 | | 2,282 |
| 3 years | 1,242.5 | | 2,282 |
| 5 years | 1,242.5 | | 3,408.16 |
| 10 years | 1,242.5 | | 3,408.16 |
| Manager | Title | Age | Since |
|---|---|---|---|
Luke Miels
CEO | Chief Executive Officer | 52 | 2025-12-31 |
Julie Brown
DFI | Director of Finance/CFO | 64 | 2023-04-30 |
James Ford
CMP | Compliance Officer | - | 2018-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Luke Miels
BRD | Director/Board Member | 52 | 2026-05-05 |
Hal Barron
BRD | Director/Board Member | 64 | 2017-12-31 |
Jonathan Symonds
CHM | Chairman | 67 | 2019-08-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/24/26 | Buy | Executive/Senior Manager | 9 | 0.0000% | ||
| 8/21/26 | Sell | Executive/Senior Manager | -28,978 | 0.0007% | ||
| 8/21/26 | Sell | Executive/Senior Manager | -49 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.53% | -2.31% | +28.60% | +34.15% | 101B | |
| +0.01% | -5.96% | +58.36% | +108.23% | 1,034B | |
| +1.48% | +0.76% | +55.34% | +71.49% | 654B | |
| +0.67% | -1.53% | +24.39% | +76.60% | 459B | |
| +0.49% | -6.58% | +34.20% | +34.59% | 343B | |
| +0.27% | +2.32% | +29.33% | +46.97% | 307B | |
| +0.12% | -4.01% | +1.06% | +11.93% | 251B | |
| +1.08% | +0.14% | +53.92% | +72.51% | 237B | |
| +2.64% | -2.00% | -17.38% | -53.64% | 202B | |
| -0.21% | +0.56% | +32.43% | +95.19% | 186B | |
| Average | +0.32% | -2.77% | +30.03% | +49.80% | 377.3B | |
| Weighted average by Cap. | +0.12% | -3.27% | +38.93% | +66.42% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 33.94B 45.83B 39.54B 37.25B 63.43B 4,330B 63.91B 441B 171B 2,214B 172B 168B 7,271B | 35.52B 47.96B 41.38B 38.98B 66.38B 4,531B 66.88B 461B 179B 2,317B 180B 176B 7,610B |
| Net income | 5.44B 7.34B 6.33B 5.97B 10.16B 693B 10.24B 70.63B 27.41B 355B 27.57B 26.96B 1,165B | 6.48B 8.76B 7.55B 7.12B 12.12B 827B 12.21B 84.26B 32.7B 423B 32.88B 32.17B 1,389B |
| Net Debt | 19.84B 26.79B 23.11B 21.77B 37.08B 2,531B 37.36B 258B 100B 1,294B 101B 98.41B 4,251B | 17.06B 23.04B 19.88B 18.72B 31.89B 2,176B 32.13B 222B 86.03B 1,113B 86.52B 84.63B 3,655B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-02 | GBX 1,861.50 | -0.53% | 4,977,854 |
| 26-09-01 | GBX 1,871.50 | +0.97% | 4,720,553 |
| 26-08-28 | GBX 1,853.50 | +0.08% | 7,790,314 |
| 26-08-27 | GBX 1,852.00 | -2.50% | 3,594,876 |
| 26-08-26 | GBX 1,899.50 | -0.31% | 3,466,438 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GSK Stock
Select your edition
All financial news and data tailored to specific country editions
